Abstract
Efficacy and safety of rivaroxaban for secondary prevention in non-valvular atrial fibrillation after cardioembolic stroke complicated by hemorrhagic transformation: a case report with a 3-year follow-up
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have